Somewhere in another Galaxy, in late December, 2024 (yet before The Second Coming of Trump), TradingView asked at it awesome Giveaway: Happy Holidays & Merry Christmas.
Here's what we answered:
1️⃣ What was your best trade this year?
Current result is 5X, to $80 per share.
Also I added more Palantir after SP500 Index inclusion in September 2024 watch here.
Current result is 2.6X, from $30 to $80 per share.
2️⃣ What is your trading goal for 2025?
It's gone 4 months or so... (Duh..? Ahaha.. 4 months, really? 😸😸😸)
Let see what's happened next at the main graph PLTR/SPX
First of all, let me explain in a few words what does this graph mean.
Conclusion

--
Best wishes,
Your Beloved PandorraResearch Team 😎
1️⃣ What was your best trade this year?
2️⃣ What is your trading goal for 2025?
Here's what we answered:
1️⃣ What was your best trade this year?
- Surely PalantirPLTR 💖
I followed Palantir all the year since January, 2024, from $16 per share, watch here.
Current result is 5X, to $80 per share.
Also I added more Palantir after SP500 Index inclusion in September 2024 watch here.
Current result is 2.6X, from $30 to $80 per share.
2️⃣ What is your trading goal for 2025?
- Once again, surely PalantirPLTR 💖
It's gone 4 months or so... (Duh..? Ahaha.. 4 months, really? 😸😸😸)
Let see what's happened next at the main graph PLTR/SPX
First of all, let me explain in a few words what does this graph mean.
- Rising (Blue) candle means Palantir
PLTR monthly return is better vs SPX
- Falling (Red) candle means Palantir
PLTR monthly return is worse vs SPX
Conclusion
- Palantir. The stock that outperformed S&P 500 Index, 11 consecutive months in a row.
- Palantir. The stock that printed 11x since inception. 5.5x over the past twelve month and 1.5x in the year 2025 (the best one result so far over the all S&P 500 Index components).
- Palantir. The stock that goes to repeat Tycoon Buffett achievement early 1990s (in 1992-93 Berkshire Hathway outperformed S&P 500 Index for a straight TWELVE MONTHS.
- Palantir. Were we right with this stock on contest and won it? Exactly! Even though our prize has been toadly strangled. 🤭
--
Best wishes,
Your Beloved PandorraResearch Team 😎
Trade closed: target reached
May 30, 2025TWELVE STRAIGHT MONTHS IN A ROW
Whew... what a day it was... 🔥🔥🔥
👉 Palantir shares outperforming the S&P500 index TWELVE MONTHS IN A ROW — that's exactly the absolutely phenomenal, fantastic (if not phantasmagorical) result recorded today, May 30, 2025, at the end of the month.
The result — Palantir repeated Buffett's 1992-93 result (unprecedented in the last several decades), when Berkshire Hathway
👉 Yes, it was a very difficult May battle, its outcome was not predetermined in advance, since both the S&P500 index and Palantir shares have been moving literally side by side all the month. And one or the other came out ahead.
Everything was finally became clear only today, on the last trading day of the month, when the Palantir bulls literally gnawed out their victory with their teeth in the last couple of hours before the Closing Bell rang out, reaching a new historical high at the end of the session, above $ 130 per share.
Just look at what a rivalry it was in May 2025, to prove the superiority 👇👇
👉 Palantir results since the beginning of 2025: +72.94% (1st place among all components of the S&P500 index). Dynamics over the last 12 months: +519.27% (also 1st place among all components of the S&P500 index).
👉 In the next publication, we will consider whether Palantir will be able to BEAT BUFFETT HIMSELF, surpassing the S&P500 index FOR THIRTEEN MONTHS IN A ROW, and thereby repeat the record of the famous technology company, which has also been held since the 1990s.
Although many can surpass the index over a 12-month distance, I repeat - doing this consistently, every month and from month to month - is an extremely difficult task.
Subscribe, boost our posts and leave your valuable thoughts at comment box. 👇👇 It's interesting with us! 🔥🔥🔥
--
Best wishes,
Your beloved PandorraResearch Team 😎
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.